Andere talen Willow Biosciences Inc.

Aandelen

WLLW

CA97111B4047

slotkoers Toronto S.E. Andere beurzen 00:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,095 ^CAD	0,00%		+5,56%	-5,00%

01/04	Willow Biosciences verkleint verlies over 2023 YOY	MT
29/03	Willow Biosciences Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Willow Biosciences Narrows 2023 Loss YOY	01/04
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	29/03
Willow Biosciences Announces Second Strategic Investment From Kalsec	01/03
Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient	21/02
Willow Biosciences Inc. announced that it expects to receive funding from Kalsec Inc.	20/02
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	31/01
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	31/01
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	31/01
Willow Biosciences Announces Collaboration with Active Pharmaceutical Ingredient Manufacturer to Manufacture More Sustainable, Cost-Effective Manufacturing Route for Their Largest Product Sold Globally	31/01
Willow Biosciences Announces Collaboration With Enterin	16/01
Willow Biosciences Inc. Announces Collaboration with Enterin, Inc. to Develop Sustainable Interimates and Active Pharmaceutical Ingredients	16/01
WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	16/01
Willow Biosciences Highlights Growth Plans for 2024, Provides 2023 Highlights	10/01
Willow Biosciences prevé que 2024 será un gran año -- Market Talk	10/01
Willow Biosciences Brief: Says Plans For "Significant" Growth In 2024	10/01
Willow Bioscience plans to advance development program with Nasdaq-listed company	11/12
Toronto Stocks Flat; Laurentian Bank of Canada Declines on Lower 4Q Profit, Revenue	07/12
Willow Biosciences and Nasdaq-listed Biopharma Co Advancing Development Program	07/12
Willow Biosciences Brief: Willow and a Nasdaq-listed biopharma company Advancing Development Program	07/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Willow Biosciences Inc.

Aandelen

WLLW

CA97111B4047

Andere talen

Filters